Last reviewed 2026-05-25 · How we verify

Linoladiol Estradiol

Medical University of Vienna · FDA-approved active Small molecule ✓ Verified May 2026 Quality 14/100

Linoladiol Estradiol is a Synthetic estrogen Small molecule drug developed by Medical University of Vienna. It is currently FDA-approved. Also known as: Montavit ATC Code G03CA03.

Linoladiol Estradiol is a small molecule used in the treatment of pelvic organ prolapse in postmenopausal women. It is administered as a vaginal cream, either as the active intervention or a placebo, in clinical trials.

At a glance

Generic name	Linoladiol Estradiol
Also known as	Montavit ATC Code G03CA03
Sponsor	Medical University of Vienna
Drug class	Synthetic estrogen
Target	Estrogen receptors (ERα and ERβ)
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

No approved indications tracked.

Pipeline indications

Common side effects

No common side effects on file.

Key clinical trials

Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Linoladiol Estradiol CI brief — competitive landscape report
Linoladiol Estradiol updates RSS · CI watch RSS
Medical University of Vienna portfolio CI

Frequently asked questions about Linoladiol Estradiol

What is Linoladiol Estradiol?

Linoladiol Estradiol is a Synthetic estrogen drug developed by Medical University of Vienna.

Who makes Linoladiol Estradiol?

Linoladiol Estradiol is developed and marketed by Medical University of Vienna (see full Medical University of Vienna pipeline at /company/medical-university-of-vienna).

Is Linoladiol Estradiol also known as anything else?

Linoladiol Estradiol is also known as Montavit ATC Code G03CA03.

What drug class is Linoladiol Estradiol in?

Linoladiol Estradiol belongs to the Synthetic estrogen class. See all Synthetic estrogen drugs at /class/synthetic-estrogen.

What development phase is Linoladiol Estradiol in?

Linoladiol Estradiol is FDA-approved (marketed).

What does Linoladiol Estradiol target?

Linoladiol Estradiol targets Estrogen receptors (ERα and ERβ) and is a Synthetic estrogen.

Drug class: All Synthetic estrogen drugs
Target: All drugs targeting Estrogen receptors (ERα and ERβ)
Manufacturer: Medical University of Vienna — full pipeline
Therapeutic area: All drugs in Cardiovascular
Also known as: Montavit ATC Code G03CA03

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing